TSH Biopharm Corporation Limited (TPEX:8432)

TSH Biopharm Corporation Revenue

TSH Biopharm Corporation had revenue of 285.82M TWD in the quarter ending March 31, 2026, a decrease of -0.45%. This brings the company's revenue in the last twelve months to 1.34B, up 11.05% year-over-year. In the year 2025, TSH Biopharm Corporation had annual revenue of 1.34B with 19.79% growth.

• Revenue (ttm): 1.34B
• Revenue Growth: +11.05%
• P/S Ratio: 1.48
• Revenue / Employee: 17.57M
• Employees: 76
• Market Cap: 1.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.34B	220.81M	19.79%
Dec 31, 2024	1.12B	304.80M	37.59%
Dec 31, 2023	810.92M	69.85M	9.43%
Dec 31, 2022	741.07M	327.58M	79.23%
Dec 31, 2021	413.48M	-34.38M	-7.68%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error